Target Audience (click to view)
This activity is designed to meet the needs of physicians.
Learning Objectives(click to view)
Upon completion of the educational activity, participants should be able to:
- Review the findings of a study that explored how the presentation of potential benefits and risks of percutaneous coronary intervention and optimal medical therapy influences patients’ beliefs and decision making.
Method of Participation(click to view)
Statements of credit will be awarded based on the participant reviewing monograph, correctly answer 2 out of 3 questions on the post test, completing and submitting an activity evaluation. A statement of credit will be available upon completion of an online evaluation/claimed credit form at www.akhcme.com/pwsept1. You must participate in the entire activity to receive credit. If you have questions about this CME/CE activity, please contact AKH Inc. at firstname.lastname@example.org.
Credit Available(click to view)
CME Credit Provided by AKH Inc., Advancing Knowledge in Healthcare
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Physician’s Weekly’s. AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
AKH Inc., Advancing Knowledge in Healthcare designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Commercial Support(click to view)
There is no commercial support for this activity.
Disclosures(click to view)
It is the policy of AKH Inc. to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
Disclosure of Unlabeled Use & Investigational Product(click to view)
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer(click to view)
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
Faculty & Credentials(click to view)
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
Dorothy Caputo, MA, BSN, RN- CE Director of Accreditation
Discloses no financial relationships with pharmaceutical or medical product manufacturers.
AKH planners and reviewers have no relevant financial relationships to disclose.
Complete the Post Test(click to view)
For patients with stable coronary disease, studies have shown that PCI does not reduce the risk for death or myocardial infarction (MI), even when it is added to optimal medical therapy (OMT). “Studies of patients undergoing elective PCI demonstrate that most patients believe that the procedure will reduce their risk for MI or death,” explains Michael B. Rothberg, MD, MPH. “The reasons behind these beliefs are unknown.”
In JAMA Internal Medicine, Dr. Rothberg and colleagues had a study published that explored how the presentation of potential benefits and risks of PCI and OMT influences patients’ beliefs and decision making. Specifically, the analysis looked at the effect of information presentation on beliefs about PCI and willingness to choose it. In an online survey, more than 1,200 adults aged 50 and older were asked to imagine having experienced chest pain and being referred to a cardiologist. They were then randomized to one of three scenarios. In the first, patients received no information about the effects of PCI on MI. In the second, participants were told specifically that PCI will not reduce the risk for MI. In the third, patients were told why PCI does not reduce the risk for MI. Then they answered questions about the procedure and whether they would choose it.
Presenting factual information affected participants’ beliefs and decisions regarding PCI (Figure). “Over 70% of participants who received no information about whether PCI would prevent MI believed that the procedure would do so,” says Dr. Rothberg. “Simply stating that PCI would not prevent an MI reduced this percentage to 39%, and explaining why PCI would not prevent MI was even more effective.” These findings suggest that physicians should explicitly state that PCI will not prevent MI because patients may otherwise assume that it will.
Participants receiving no information were also the most likely to choose PCI. “Believing that PCI could prevent MI was the strongest predictor of participants choosing PCI,” Dr. Rothberg says. “Also, participants who received no information were least likely to agree to use medications while those receiving explanatory information were most likely. The impact was really striking given that it was limited to a few lines of text and that there was no opportunity to ask clarifying questions.”
Assessing Knowledge Recall
The research team also asked participants to recall what their physician said about the benefits of PCI. Only one in five patients receiving no information could correctly recall that the physician said nothing. However, about two-thirds of patients who received explicit or explanatory information remembered the physician saying there would be no reduction in risk of MI.
In addition, more than half of patients in the group with no information falsely remembered that their physician had told them that PCI would reduce their risk for an MI. Rates were much lower for patients in the other groups. Furthermore, about one-fifth of patients still believed that PCI would prevent an MI despite remembering the physician saying it would not. These findings illustrate that deeply ingrained patient beliefs may have an important impact.
Several strategies have been proposed to improve patient understanding when deciding on PCI, including a standardized consent template and decision aids. These interventions are still being tested but may be helpful in the future. In addition, several factors may be at play. For example, not all patients’ misconceptions can be overcome easily. Cardiologists may also mistakenly believe they are successfully communicating with patients. Self-assessments of how these messages are being delivered could become an important quality improvement initiative in the future.
Dr. Rothberg points out that another important misconception is patients can choose between OMT and PCI to reduce their risk of MI. “OMT is recommended regardless of whether or not a patient receives a stent,” he says. “Communicating the benefits of PCI remains challenging for clinicians but is essential to fostering informed-decision making. Providing even small amounts of information to patients has the potential to affect their beliefs and decisions.” The study notes that this can be accomplished without requiring patients to watch lengthy videos or having physicians spend too much time with patients. In light of the findings, Dr. Rothberg recommends studies be undertaken to assess the effects of brief interventions on patient misconceptions regarding the benefits of elective PCI.
Readings & Resources (click to view)
Rothberg MB, Scherer L, Kashef MA, et al. The effect of information presentation on beliefs about the benefits of elective percutaneous coronary intervention. JAMA Intern Med. 2014;174:1623-1629. Available at: http://archinte.jamanetwork.com/article.aspx?articleid=1898876.
Rothberg MB, Sivalingam SK, Ashraf J, et al. Patients’ and cardiologists’ perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med. 2010;153:307-313.
Coylewright M, Shepel K, Leblanc A, et al. Shared decision making in patients with stable coronary artery disease: PCI choice. PLoS One. 2012;7:e49827.
Oshima Lee E, Emanuel EJ. Shared decision making to improve care and reduce costs. N Engl J Med. 2013;368:6-8.
Stergiopoulos K, Boden WE, Hartigan P, et al. Percutaneous coronary intervention outcomes in patients with stable obstructive coronary artery disease and myocardial ischemia: a collaborative meta-analysis of contemporary randomized clinical trials. JAMA Intern Med. 2014;174:232-240.